Great post zeno. I agree that the statements do imply things should occur in the shorter term. Does anyone have any ideas what sort of outcomes rgs could expect from other licencee deals?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025